INNV
$6.80
Innovage Holding
$.07
1.04%
INNV
Earnings Whisper ®
N/A
1st Quarter September 2021
Consensus:  $0.05
Revenue:  $171.65 Mil
Tuesday
Nov 9
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when INNV reports earnings?
Beat
Meet
Miss

Where is INNV's stock price going from here?
Up
Flat
Down
Stock chart of INNV
Analysts
Summary of analysts' recommendations for INNV
Score
Grade
Pivots
Resistance
$7.01
$6.90
$6.82

$6.71

Support
$6.63
$6.52
$6.44
Tweet
Growth
Description
InnovAge Holding Corp. is a healthcare delivery platform. The Company delivers its patient-centered care through the InnovAge Platform. InnovAge Platform is focused on frail, dual-eligible seniors as well as it serve participants primarily through Program of All-inclusive Care for the Elderly. InnovAge Holding Corp. is based in DENVER, United States.
Peers
Vertex PharmaceuticalsUltragenyx PharmaceuticalRegeneron PharmaceuticalsBioMarin PharmaceuticalBristol-Myers SquibbInterCeptMerck & Co.Eli LillyZoetisPfizer